Hormone Receptor-positive Breast Cancer
📧 Sign up to get email alerts when something new happens for Hormone Receptor-positive Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic [Phase 2]
A randomized Phase II trial assessed letrozole with or without dasatinib in postmenopausal women with hormone receptor-positive, HER2-negati…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer
This ClinicalTrials.gov entry NCT01561443 reports on treatment patterns for postmenopausal women with hormone receptor-positive breast cance…